Sponsored Links

Study Shows Revolutionary New Treatment From Pulmonx Is Consistently Effective In Treating Emphysema PDF Print E-mail
Medical News - COPD
Pulmonx Inc. has announced new clinical data from its Chartis multi-center study 1, presented at the American Thoracic Society's 2011 International Conference. This definitive data clearly demonstrates that by using the Chartis® Pulmonary Assessment System to plan Zephyr® valve treatments physicians can consistently treat a broad spectrum of emphysema patients...

Read more: COPD News From Medical News Today